Search

Your search keyword '"Hemophilia -- Reports -- Forecasts and trends"' showing total 231 results

Search Constraints

Start Over You searched for: Descriptor "Hemophilia -- Reports -- Forecasts and trends" Remove constraint Descriptor: "Hemophilia -- Reports -- Forecasts and trends"
231 results on '"Hemophilia -- Reports -- Forecasts and trends"'

Search Results

1. Hemophilia B Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Pipeline, Epidemiology and Companies by DelveInsight

2. Global Plasma Protein Therapeutics Market to Touch ~USD 40 Billion Mark by 2030

3. Hemophilia A Market Size in the 7MM was ~USD 11,200 Million in 2023, estimated DelveInsight

4. Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin) Insights & Forecast 2024-2028, Featuring CSL, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion & ADMA Biologics

5. Global Blood Group Typing Industry Report 2024-2028: Strategic Automation Integration to Revolutionize Blood Group Testing - ResearchAndMarkets.com

6. Global Cell and Gene Therapies in Hemophilia A & B Analysis Report 2024: Market to Reach $2.2 Billion by 2029 - Major Players Are Expected To Intensify Competition

7. Acquired hemophilia A Market to Witness an Upsurge in Growth by 2032, Examines DelveInsight

8. Hemophilia B Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharmaceuticals, CSL Behring, uniQure

9. Hemophilia Market Size in the 7MM is Expected to Grow by 2032 | DelveInsight

10. Acquired Hemophilia A Market Size is Expected to Grow by 2032 | DelveInsight

11. Plasma Derived Therapies Market Immunoglobulin, Hemophilia, Specialty, and Albumin Insights & Forecast 2024-2028, Featuring CSL, Grifols, Takeda Pharmaceutical, Octapharma, Kedrion & ADMA Biologics - ResearchAndMarkets.com

12. Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight

13. Global Hemophilia Treatment Regimen and Therapy Market Insights & Forecasts, 2023-2024 and 2028 Featuring Pfizer, Bayer, Sanofi, Takeda Pharmaceutical, Novo Nordisk and CSL - ResearchAndMarkets.com

14. The Business Research Company: Hemophilia Market Expected to Reach Value of $19.4 Billion By 2028

15. Global Rare Hemophilia Factors (I, II, VII) Market Size, Share and Trends Analysis Report 2023-2030

16. Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028

17. Rising Prevalence of Bleeding Disorders Drives Robust Growth in the Global Bleeding Disorders Treatment Market to 2028

18. Rising Prevalence of Bleeding Disorders Drives Robust Growth in the Global Bleeding Disorders Treatment Market to 2028

19. Hemophilia A Market to Exhibit Growth at a Remarkable CAGR During the Study Period (2019-2032) | DelveInsight

20. Advancements in Hemophilia Treatment Propel Global Bleeding Disorders Market to New Heights by 2032 - ResearchAndMarkets.com

21. Advancements in Hemophilia Treatment Propel Global Bleeding Disorders Market to New Heights by 2032

22. Hemophilia Market Size & Share to Surpass $ 18.77 Billion by 2030 | Vantage Market Research

23. Hemophilia Market Size, Share and Trends Analysis Report 2023-2030

24. Hemophilia A Market expected to rise | Companies - Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd., Bayer, Ultragenix pharmaceutical

25. Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies to Look Out for - Pfizer, Sanofi, CSL Behring, Freeline, Genentech, Shire, Spark, Novo Nordisk, Sangamo, UBI, uniQure

26. Prothrombin Complex Concentrate Market Size, Share, and Analysis, By Product, By Application, By End-Use and Regional Forecasts, 2022-2032

27. Prothrombin Complex Concentrate Market Size, Share, and Analysis, By Product, By Application, By End-Use and Regional Forecasts, 2022-2032

28. Viral Vector Manufacturing Global Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~19% by 2028 | DelveInsight

29. Viral Vector Manufacturing Global Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~19% by 2028 | DelveInsight

31. Global Rare Hemophilia Factors Market to Reach $471.2 Million by 2030

32. Global Rare Hemophilia Factors Market to Reach $471.2 Million by 2030

33. 80+ Active Companies working to develop 80+ Pipeline Therapies for Hemophilia Treatment Landscape | Major Companies - Novo Nordisk, Amunix, Pfizer, and Others

34. Hemostasis Valves Market Revenue to Cross USD 245.6 Mn by 2031 with CAGR of 4.8% | Transparency Market Research

35. Global Hemophilia Market Size To Grow USD 17.8 Billion By 2030 | CAGR of 7.55%

36. Hemophilia A Pipeline Analysis Demonstrates Novel 35+ Therapies at the Horizon Expected to Transform the Treatment Paradigm | DelveInsight

37. Global Bleeding Disorders Treatment Market Research Report 2023: A $22 Billion Market by 2030 - Emerging Therapies|New Product Launches|Investments to Spur Market Demand

38. Hemophilia Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

39. Bleeding Disorder Treatment Market Size is expected to reach at USD 26,177 Million by 2030

40. Global Rare Hemophilia Factors Market to Reach $387.5 Million by 2027

41. Hemophilia Treatment Market Poised for Revenue Worth US$21.3 Bn by 2027 End: Fairfield Market Research

42. Hemophilia Market Size Will Attain USD 21.9 Billion by 2030 growing at 6.9% CAGR - Exclusive Report by Acumen Research and Consulting

43. Hemophilia Market Size Will Attain USD 21.9 Billion by 2030 growing at 6.9% CAGR - Exclusive Report by Acumen Research and Consulting

44. Research and Markets Brings Out Report: Bleeding Disorders Treatment

45. The Worldwide Hemophilia Treatment Industry is Projected to Reach $26.9 Billion by 2031

46. Hemophilia A Market Landscape Set to Witness Growth at a CAGR for the Study Period 2019-32 in the 7MM | DelveInsight

48. Hemophilia Market Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

49. The Worldwide Hemophilia Treatment Industry is Projected to Reach $26.9 Billion by 2031

50. Hemophilia Pipeline Insights Featuring 75+ Companies | Clinical Trial Research Evaluation Report By DelveInsight

Catalog

Books, media, physical & digital resources